Intra-arterial Chemotherapy for Malignant Tumors of Head and Neck Region Using Three Types of Modified Injection Method

Abstract

Relatively higher infusion rate in the intra-arterial chemotherapy (IA chemotherapy) could induce the higher concentration and the more sufficient distribution of chemotherapeutic agents on tumors. To get the relatively higher infusion rate in IA chemotherapy, we used three types of injection method: high-flow injection, high-dose injection with detoxification and flow-controlled injection method for the treatment of malignant brain tumors, skull base tumors and head and neck tumors.

Between January 1997 and October 2001, twenty-seven patients (mean age 61 y.o.) with supratentorial glioblastoma (4 cases), supratentorial anaplastic astrocytoma (1), CNS lymphoma (2), matastatic skull base tumors (3), and neck tumors (15 squamous cell carcinoma, 1 malignant melanoma and 1 neuroblastoma) received our three types of IA chemotherapy. Sixty-five consecutive procedures were performed. Conventional radiation therapy and/or surgical removal were performed in some of these patients. The median follow-up period was 10 months ranging 2 to 56 months.

Fifteen (55.6%) and 6 (22.2%) of 27 patients achieved complete response (CR) and partial response (PR) respectively after initial treatment [CR+PR: 21 (77.8%)]. All responded patients showed clinical improvement. The response rate declined to 55.6% at the end of follow-up period. Eighteen patients are still alive and 15 of them show no evidence of local recurrence. The median post treatment survival was 12 months. There was no serious complication except transient nausea in 4 of 27 (14%) patients, vertigo and granulocytopenia in 1 each (3%) of 27 patients.

Our modified IA chemotherapy has provided favorable clinical and radiological results without technical difficulties and serious complications.

Keywords

intra-arterial chemotherapy malignant brain tumor head and neck region tumor

Get full access to this article

View all access options for this article.

References

Aoki

Terada

: Supraophthalmic chemotherapy with long tapered catheter: distribution evaluated with intraarterial and intravenous Tc-99m HMPAO. Radiology 188 (2): 347–350, 1993.

Diaz

Jr Kies

: Chemotherapy for skull base cancers. Otolaryngol Clin North Am 34 (6): 1079–1085, 2001.

Doolittle

Miner

: Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 88 (3): 637–647, 2000.

Fine

Dear

: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585–2597, 1993.

Gelman

Chakeres

: Brain tumors: complications of cerebral angiography accompanied by intraarterial chemotherapy. Neuroradiology 213: 135–140, 1999.

Gobin

Cloughesy

: Intraarterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery. Radiology 218 (3): 724–732, 2001.

Hamana

Motoyama

: Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma. Am J Clin Oncol 24: 241–246, 2001.

Hodozuka

Sako

: Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion. J Neuro-Onco 15: 79–86, 1993.

Kochi

Kitamura

: Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma. J Neurooncol 49 (1): 63–70, 2000.

10.

Madajewicz

Chowhan

: Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer 88 (10): 2350–2356, 2000.

11.

Morikawa

Mori

: Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy. Biol Pharm Bull 22 (4): 428–431, 1999.

12.

Newman

Robbins

: Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head and Neck 24 (1): 68–77, 2002.

13.

Nibu Ki

Sugasawa

: Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer 94 (5): 1476–1482, 2002.

14.

Robbins

: Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer. Int Radiat Oncol Biol: 38: 263–271, 1997.

15.

Saris

Blasberg

: Intravascular streaming during carotid artery infusions. J Neurosurg 74: 763–772, 1991.

16.

Sawada

Maruyama

: Balloon occluded arterial infusion (BOAI) therapy in patients with progressive cervical carcinoma. Nippon Sanka Fujinka Gakkai Zasshi 41 (3): 293–300, 1989.

17.

Takeda

Diksic

: Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model. Journal of Neuro-Oncology 41: 235–246, 1999.

18.

Takeda

Inoue

: High-flow-intraarterial injection of chemotherapeutic agents in treatment of recurrent malignant glioma. Neuro-Oncology 7 (2): 46–51, 1997.

19.

Tfayli

Hentschel

: Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J Neurooncol 42 (1): 73–77, 1999.

20.

Galmarini

: Heterogeneous distribution of tumor blood supply affects the response to chemotherapy in patients with head and neck cancer. Microcirculation 7: 405–410, 2000.

21.

Shapiro

Green

: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772–781, 1992.